Sentences with phrase «share dividend growth»

What makes this fund interesting is that there is a dividend - growth factor married to the higher yield requirement: To be eligible for the index, a stock must have five - year non-negative per - share dividend growth.

I also share dividend growth stock ideas and thoughts.

I also share dividend growth stock ideas and... Continue reading Q4 - 2017 Dividend — The Dividend Report

I will also share dividend growth stock ideas and... Continue reading Q3 - 2016 Dividend Report

I will also share dividend growth stock ideas.

I will also share dividend growth stock ideas and... Continue reading Q3 - 2017 Dividend — The Dividend Report

I will also share dividend growth stock ideas and... Continue reading Q4 - 2016 Dividends — The Dividend Report

I will also share dividend growth stock ideas and... Continue reading Q3 - 2016 Dividend Report

I will also share dividend growth stock ideas and thoughts.

I will also share dividend growth stock ideas.

I will also share dividend growth stock ideas and... Continue reading Q3 - 2017 Dividend — The Dividend Report

Through 2017 I would again like to recommit to sharing my dividend growth journey with readers.

Not exact matches

Fukakusa was circumspect in addressing the question, writing the bank will «look for the right balance between investing in our businesses for long - term growth, returning capital to shareholders through dividends and share buybacks, and pursuing select acquisitions that fit our strategy and risk appetite.»

I am pleased to announce that our Board of Directors declared a 7 % increase in our quarterly cash dividend to $ 0.77 per share, marking 14 consecutive years of dividend increases with a compound annual growth rate of about 10 % over that period.

When you purchase a broad swath of equities, say an S&P 500 index fund, the returns you can expect over the next decade or so comprise four building blocks: the starting dividend yield, projected growth in real earnings per share, expected inflation, and the expected change in «valuation» — that is, the expansion or contraction in the price / earnings (P / E) multiple.

Collect a Check When stock price growth is sluggish, dividends account for a much bigger share of investors» gains.

But in a letter sent last month to CEOs of the S&P 500 and large companies in Europe, the Middle East, Africa, and Asia Pacific, BlackRock CEO Larry Fink criticized corporate leaders» use of share buybacks and dividends when they might be better served by investing in «innovation, skilled workforces or essential capital expenditures necessary to sustain long - term growth.»

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

We see earnings - per - share (EPS) growth and dividends fueling returns.

In a slow growth economy, dividends will be increasingly in focus as providing the lion's share of yield to investors.

The U.S. rate hike that the market is 100 percent certain will be delivered this week did not stop Dividend Equity Funds from recording their biggest inflow since the record setting $ 9.4 billion they took in exactly three years ago, with investors translating recent earnings per share growth and expected repatriation of foreign cash piles into bigger dividend Dividend Equity Funds from recording their biggest inflow since the record setting $ 9.4 billion they took in exactly three years ago, with investors translating recent earnings per share growth and expected repatriation of foreign cash piles into bigger dividend dividend payouts.

This growth rate is the compound annual growth rate of cash dividends per common share of stock over the last 5 years.

Our fundamental belief is that growth in corporate profits and the resultant dividend growth will eventually lead to share price appreciation.

We decided to use some of this to rebalance the portfolio a bit more in an attempt to get more dividend growth shares.

As part of my process towards increasing and sharing my passive income, I post my trading activity for my dividend growth portfolios.

This is normally accomplished by taking the dividends earned on each share and dividing it by the share's current market value, and then adding the share's dividend growth rate to the equation to equal the rate or return required.

Despite promising growth prospects in the Permian and other efforts supporting the dividend and the potential for share buybacks, a widening valuation multiple at Chevron Corporation (NYSE: CVX) is not justifiable, according to «Further Upside For Chevron Is Unjustified, BMO Analyst Says» by Shanthi Rexaline.

After taking a look at the fund's low yield and lack of consistent dividend growth, I decided to sell all the shares.

With a long history of profit growth, overly pessimistic expectations baked into the stock, and a 6 % (dividend plus share buybacks) yield, this week's Long Idea is Eaton Corporation (ETN).

I share these figures along with monthly income / expenses to not only track my progress towards financial independence but also to hopefully show others that it is possible to get started with dividend growth investing with a low income.

As such, this past week on February 9th, I purchased 25 shares of Emerson Electric (EMR) and 20 shares of Johnson and Johnson (JNJ), two stalwarts of dividend growth.

Important factors that may affect the Company's business and operations and that may cause actual results to differ materially from those in the forward - looking statements include, but are not limited to, increased competition; the Company's ability to maintain, extend and expand its reputation and brand image; the Company's ability to differentiate its products from other brands; the consolidation of retail customers; the Company's ability to predict, identify and interpret changes in consumer preferences and demand; the Company's ability to drive revenue growth in its key product categories, increase its market share, or add products; an impairment of the carrying value of goodwill or other indefinite - lived intangible assets; volatility in commodity, energy and other input costs; changes in the Company's management team or other key personnel; the Company's inability to realize the anticipated benefits from the Company's cost savings initiatives; changes in relationships with significant customers and suppliers; execution of the Company's international expansion strategy; changes in laws and regulations; legal claims or other regulatory enforcement actions; product recalls or product liability claims; unanticipated business disruptions; failure to successfully integrate the Company; the Company's ability to complete or realize the benefits from potential and completed acquisitions, alliances, divestitures or joint ventures; economic and political conditions in the nations in which the Company operates; the volatility of capital markets; increased pension, labor and people - related expenses; volatility in the market value of all or a portion of the derivatives that the Company uses; exchange rate fluctuations; disruptions in information technology networks and systems; the Company's inability to protect intellectual property rights; impacts of natural events in the locations in which the Company or its customers, suppliers or regulators operate; the Company's indebtedness and ability to pay such indebtedness; the Company's dividend payments on its Series A Preferred Stock; tax law changes or interpretations; pricing actions; and other factors.

While the market continues to be volatile I continue to buy shares of high quality dividend growth companies.

With its strong dividend growth rates AFL should make a great long - term holding and also give me some exposure to the financial sector since I recently sold my shares in Powershares Financial Preferred ETF (PGF).

Important factors that may affect the Company's business and operations and that may cause actual results to differ materially from those in the forward - looking statements include, but are not limited to, operating in a highly competitive industry; changes in the retail landscape or the loss of key retail customers; the Company's ability to maintain, extend and expand its reputation and brand image; the impacts of the Company's international operations; the Company's ability to leverage its brand value; the Company's ability to predict, identify and interpret changes in consumer preferences and demand; the Company's ability to drive revenue growth in its key product categories, increase its market share, or add products; an impairment of the carrying value of goodwill or other indefinite - lived intangible assets; volatility in commodity, energy and other input costs; changes in the Company's management team or other key personnel; the Company's ability to realize the anticipated benefits from its cost savings initiatives; changes in relationships with significant customers and suppliers; the execution of the Company's international expansion strategy; tax law changes or interpretations; legal claims or other regulatory enforcement actions; product recalls or product liability claims; unanticipated business disruptions; the Company's ability to complete or realize the benefits from potential and completed acquisitions, alliances, divestitures or joint ventures; economic and political conditions in the United States and in various other nations in which we operate; the volatility of capital markets; increased pension, labor and people - related expenses; volatility in the market value of all or a portion of the derivatives we use; exchange rate fluctuations; risks associated with information technology and systems, including service interruptions, misappropriation of data or breaches of security; the Company's ability to protect intellectual property rights; impacts of natural events in the locations in which we or the Company's customers, suppliers or regulators operate; the Company's indebtedness and ability to pay such indebtedness; the Company's ownership structure; the impact of future sales of its common stock in the public markets; the Company's ability to continue to pay a regular dividend; changes in laws and regulations; restatements of the Company's consolidated financial statements; and other factors.

The $ 3.46 - per - share dividend currently yields a solid 2.6 %, which, when coupled with its steady growth in revenue, suggests that Diageo is a stock investors can count on when times are good, but even more when times get tough.

Bought in 2012 at $ 37 / share and annual dividend of $ 1.44 2015 share price of $ 79 / share and annual dividend of $ 1.84 Share price capital gain = 113 %, Total dividend growth = 27.7 % Prune Ratio: 113 / 27.7 =share and annual dividend of $ 1.44 2015 share price of $ 79 / share and annual dividend of $ 1.84 Share price capital gain = 113 %, Total dividend growth = 27.7 % Prune Ratio: 113 / 27.7 =share price of $ 79 / share and annual dividend of $ 1.84 Share price capital gain = 113 %, Total dividend growth = 27.7 % Prune Ratio: 113 / 27.7 =share and annual dividend of $ 1.84 Share price capital gain = 113 %, Total dividend growth = 27.7 % Prune Ratio: 113 / 27.7 =Share price capital gain = 113 %, Total dividend growth = 27.7 % Prune Ratio: 113 / 27.7 = 4.03

Annual Dividend: $ 2.63 Dividend Yield: 5.12 % Dividend Growth History: 22 years Payout Ratio: 83.4 % Earnings Per Share: $ 1.10 PE Ratio: 46.60

For instance, 3M increased its dividend by 16 % in fiscal 2017, backed by 12.4 % growth in adjusted earnings per share and free cash flow generation of nearly $ 4.9 billion, or 100 % of its net income.

Companies in mature industries like consumer staples and utilities have fewer growth opportunities so they can share cash flow with investors through dividends rather than plow it all back into projects.

If the stock price remains stable I will not sell the entire position due to the attractive dividend growth rate but instead prune it back by selling some shares to capitalize on the gains and reinvest the proceeds to help with income and diversification.

Bought in 2013 at $ 77 / share and annual dividend of $ 2.40 2015 share price of $ 80 / share and annual dividend of $ 2.65 Share price total return = 3 %, Total Dividend Growth = 10.4 % Prune Ratio: 3 / 10.4 =share and annual dividend of $ 2.40 2015 share price of $ 80 / share and annual dividend of $ 2.65 Share price total return = 3 %, Total Dividend Growth = 10.4 % Prune Ratio: 3 / 10.dividend of $ 2.40 2015 share price of $ 80 / share and annual dividend of $ 2.65 Share price total return = 3 %, Total Dividend Growth = 10.4 % Prune Ratio: 3 / 10.4 =share price of $ 80 / share and annual dividend of $ 2.65 Share price total return = 3 %, Total Dividend Growth = 10.4 % Prune Ratio: 3 / 10.4 =share and annual dividend of $ 2.65 Share price total return = 3 %, Total Dividend Growth = 10.4 % Prune Ratio: 3 / 10.dividend of $ 2.65 Share price total return = 3 %, Total Dividend Growth = 10.4 % Prune Ratio: 3 / 10.4 =Share price total return = 3 %, Total Dividend Growth = 10.4 % Prune Ratio: 3 / 10.Dividend Growth = 10.4 % Prune Ratio: 3 / 10.4 = 0.28

Where: D = Expected dividend per share one year from now k = Required rate of return for equity investor G = Growth rate in dividends (in perpetuity)

JNJ's dividend has risen from $ 1.28 per share a decade ago to $ 2.95 per share now, for a 9 % annual growth rate.

Bought in 2011 at $ 12.22 / share and annual dividend of $ 0.63 2015 share price at $ 16.44 / share and annual dividend of $ 0.67 Share price capital gain = 32 %, Total dividend growth = 6.9 % Prune Ratio: 32 / 6.9 =share and annual dividend of $ 0.63 2015 share price at $ 16.44 / share and annual dividend of $ 0.67 Share price capital gain = 32 %, Total dividend growth = 6.9 % Prune Ratio: 32 / 6.9 =share price at $ 16.44 / share and annual dividend of $ 0.67 Share price capital gain = 32 %, Total dividend growth = 6.9 % Prune Ratio: 32 / 6.9 =share and annual dividend of $ 0.67 Share price capital gain = 32 %, Total dividend growth = 6.9 % Prune Ratio: 32 / 6.9 =Share price capital gain = 32 %, Total dividend growth = 6.9 % Prune Ratio: 32 / 6.9 = 4.63

Miller also expects Discovery to initiate a dividend of $ 0.30 a share, given the slowing growth rate, an improvement in 2016 free cash flow (FCF) of 9.5 percent and $ 1.36 billion plus in FCF expected in 2017.

Shares of growth companies may not pay out the dividend you get from a value stock but you can create your own dividend by selling a few sShares of growth companies may not pay out the dividend you get from a value stock but you can create your own dividend by selling a few sharesshares.

A yield well over 6 %, management guidance for double - digit dividend growth, and the possibility that shares are 59 % undervalued means this could be the single greatest opportunity in the market for long - term dividend growth investors.

The company has an expected total return of 13 % to 15 % a year from dividends (5 %) and earnings - per - share growth (8 % to 10 %).

These positive earnings drivers were more than offset by the combined impact of several factors, including increased energy - related provisions for credit losses, a 17 basis point decline in net interest margin, moderate growth of non-interest expenses, the addition of acquisition - related contingent consideration fair value changes reflecting performance within CWB Maxium Financial (CWB Maxium), higher preferred share dividends, and the 20 % increase to CWB's income tax rate in Alberta.